| 0.5703 0.037 (7%) | 10-23 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.98 | 1-year : | 1.21 |
| Resists | First : | 0.83 | Second : | 1.04 |
| Pivot price | 0.65  |
|||
| Supports | First : | 0.5 | Second : | 0.42 |
| MAs | MA(5) : | 0.57 |
MA(20) : | 0.71 |
| MA(100) : | 1.09 |
MA(250) : | 4.23 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 11.1 |
D(3) : | 13.1 |
| RSI | RSI(14): 29.6 |
|||
| 52-week | High : | 26.6 | Low : | 0.5 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ IVF ] has closed above bottom band by 30.1%. Bollinger Bands are 31.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.59 - 0.59 | 0.59 - 0.59 |
| Low: | 0.52 - 0.53 | 0.53 - 0.53 |
| Close: | 0.57 - 0.58 | 0.58 - 0.58 |
INVO Fertility, Inc. is a profitable enterprise primarily focused on delivering fertility services. Beyond this core business, the company actively develops clinical-stage therapies targeting oncology and autoimmune disorders. The firm was established on January 5, 2007, and its operations are based in Sarasota, Florida.
Fri, 23 Oct 2026
INVO Fertility, Inc. Estimates – NASDAQ:IVF - TradingView
Thu, 01 Oct 2026
INVO Fertility, Inc.'s (NASDAQ:IVF) Shift From Loss To Profit - Simply Wall Street
Fri, 28 Aug 2026
INVO Fertility (IVF) details $15M–$50M Alumni share deal - Stock Titan
Fri, 28 Aug 2026
INVO Fertility to Participate in H.C. Wainwright's 28th Annual Global Investment Conference - Moomoo
Mon, 17 Aug 2026
INVO Fertility Q2 2026: Revenue up 17% to $2.18M; clinic platform profitable on clinic-level EBITDA - TradingView
Mon, 17 Aug 2026
INVO Fertility Surges After Q2 Revenue Growth and Profitable Clinic Operations - Quiver Quantitative
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 5 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 0.8 (%) |
| Held by Institutions | 16.8 (%) |
| Shares Short | 50 (K) |
| Shares Short P.Month | 368 (K) |
| EPS | 127.94 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 7.01 |
| Profit Margin | -92.4 % |
| Operating Margin | -59.3 % |
| Return on Assets (ttm) | -16.5 % |
| Return on Equity (ttm) | -72.7 % |
| Qtrly Rev. Growth | 16.7 % |
| Gross Profit (p.s.) | 0.57 |
| Sales Per Share | 1.63 |
| EBITDA (p.s.) | -1.17 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -5 (M) |
| Levered Free Cash Flow | -5 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0.08 |
| Price to Sales | 0.35 |
| Price to Cash Flow | -0.56 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|